Structures by: Bond C. J.
Total: 4
(2,2',2'',2'''-(1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetrayl)tetraacetamide)-cobalt(ii) dithiocyanate.
C18H36CoN8O4,2(CNS)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 2 279-284
a=8.7005(6)Å b=12.9672(11)Å c=11.9397(11)Å
α=90° β=104.610(3)° γ=90°
(2,2',2'',2'''-(1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetrayl)tetraacetamide)-cobalt(ii) diperchlorate monohydrate
C18H36CoN8O4,2(ClO4),H2O
Dalton transactions (Cambridge, England : 2003) (2020) 49, 2 279-284
a=8.8541(6)Å b=9.9859(8)Å c=17.8607(14)Å
α=92.863(2)° β=103.261(2)° γ=111.451(2)°
(2,2',2'',2'''-(1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetrayl)tetraacetamide)-cobalt(ii) tetrathiocyanatocobaltate trihydrate.
C18H36CoN8O4,3(H2O),C4CoN4S4
Dalton transactions (Cambridge, England : 2003) (2020) 49, 2 279-284
a=10.0766(5)Å b=10.7225(6)Å c=17.5231(9)Å
α=75.030(2)° β=74.215(2)° γ=82.412(2)°
2-(Pyridin-4-yl)-1<i>H</i>-benzimidazole
C12H9N3
Acta Crystallographica Section E (2013) 69, 6 o869
a=6.0602(14)Å b=11.610(3)Å c=13.892(4)Å
α=90° β=101.838(8)° γ=90°